Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: new + medtronic + heart  Related to the article below (Last Update: 8/5/2008)

UPDATE: US DOJ Probing Marketing For Bile-Duct Stents
CNNMoney.com -
Medtronic Inc. (MDT) spokesman Daniel Beach declined comment on whether that company, which also makes biliary stents, had recently received a subpoena. ...
Routine shock-energy testing in primary-prevention ICDs questioned ...
TheHeart.Org, NY -
Those getting devices received single-lead Medtronic ICDs programmed to deliver only shock therapy with a maximum output of 30 J. Importantly, ...
Medtronic paid new CEO Bill Hawkins $7.1 million
Forbes, NY - Jul 18, 2008
Fridley-based Medtronic (nyse: MDT - news - people ) makes devices such as implantable heart defibrillators, spinal implants, and insulin pumps. ...MDT
Heart Valve Puts Edwards Into Wall Street Play With 60% Premium
Bloomberg - Jul 9, 2008
Johnson & Johnson of New Brunswick, New Jersey, and Medtronic Inc., based in Minneapolis, announced plans within four days of each other last month to enter ...
eResearch Technology Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha, NY -
Michael was previously Chief Operating Officer of Medtronic, Incorporated and served as Senior Vice President and President of Europe, Canada, Latin America ...ERES
Chennai gets India's first heart implant training centre
Economic Times, India - Jul 19, 2008
CHENNAI: India has got its first training centre for doctors to learn how to place implants in the heart. Medtronic, a US-based medical technology service ...
Medtronic launches its first TPTC in India Business Standard
all 9 news articles »  MDT
Delaware known as haven for patent suits
The News Journal, DE - Aug 2, 2008
Minneapolis-based Medtronic Inc., the largest maker of heart devices, chose Marshall, Texas, to sue Massachusetts-based Boston Scientific Corp. over ...
Medtronic wins approval on heart device in Japan
Bizjournals.com, NC - Jul 15, 2008
Medtronic Inc. won approval in Asia on an implantable heart device that treats unexplained fainting episodes. Fridley-based Medtronic (NYSE: MDT) received ...
Medtronic Launches First Insertable Cardiac Monitor in Japan Business Wire (press release)
all 14 news articles »  MDT
Putting the boot to preemption
Point of Law, NY -
Medtronic, the Medical Device Safety Act of 2008, S. 3398. The bill is companion to HR 6381, and another attack on the principle of federal premption. ...
The best medicine
Irish Times, Ireland - Jul 17, 2008
Medtronic's Endeavor cardiac stent, a drug-releasing metal tube used to prop open diseased arteries, is made at the US company's Galway facility. ...MDT
Source: Google News

… Treatment of Congestive Heart Failure: Preliminary Results of the Medtronic Inc. InSync Study -
D GRAS, P MABO, T TANG, O LUTTIKUIS, R CHATOOR, AK … - Pacing and Clinical Electrophysiology, 1998 - Blackwell Synergy
... InSync Group, Medtronic Inc. Early results regarding implant procedures of a new
biventricular atrial ... of multisite pacing in end-stage heart Failure, (abstract ...

… pacing in advanced heart failure-preliminary results of the Medtronic Inc. InSync study -
C Alonso, C Leclercq, F Victor, H Mansour? - The American Journal of Cardiology, 1999 - ingentaconnect.com
... failure - preliminary results of the Medtronic Inc ... for treating patients with drug
refractory heart failure and ... term clinical effectiveness of that new treatment ...

Pathology of Substitute Heart Valves: New Concepts and Developments -
FJ Schoen, RJ Levy - Journal of Cardiac Surgery, 1994 - Blackwell Synergy
... ation of the impact of new tissue treatments ... that coats the normal mammalian heart
valves is ... several centers and commercially (eg, Medtronic FreestyleR), which ...

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation … -
AR Leon, JM Greenberg, N Kanuru, CM Baker, FV Mera … - Journal of the American College of Cardiology, 2002 - Am Coll Cardio Found
... heart failure: preliminary results of the Medtronic Inc ... assess cardiac resynchronization
therapy in heart failure patients ... Text]; Varma C, Callaghan PO, New C, et ...

Ongoing right ventricular hemodynamics in heart failure clinical value of measurements derived from … -
PB Adamson, A Magalski, F Braunschweig, M Bohm, D … - Journal of the American College of Cardiology, 2003 - Am Coll Cardio Found
... of 21 and 75 years, with New York Heart ... and implantation The Chronicle IHM (Medtronic,
Inc., Minneapolis ... ongoing right ventricular (RV) pressures, heart rate (HR ...

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite … -
C Linde, C Leclercq, S Rex, S Garrigue, T Lavergne … - Journal of the American College of Cardiology, 2002 - Am Coll Cardio Found
... reliability and validity of a new measure?the ... as a supplemental treatment of congestive
heart failure: preliminary results of the Medtronic Inc. ...

Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure -
GH Bardy, KL Lee, DB Mark, JE Poole, DL Packer, R … - New England Journal of Medicine, 2005 - content.nejm.org
... model 7223, Medtronic). All patients were followed until October 31, 2003. Patients
had to be at least 18 years of age and have New York Heart Association (NYHA ...

A two-year, three institution experience with the Medtronic Octopus: systematic off-pump surgery -
TH Spooner, JC Hart, J Pym - The Annals of Thoracic Surgery, 1999 - Soc Thorac Surgeons
... mounted, Octopus II for beating heart CAB (Medtronic, Inc ... completed Oc- topus CAB
(Medtronic, Inc), performed ... infarc- tion (0.8%), and new intraaortic balloon ...

… by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure -
CM Yu, E Chau, JE Sanderson, K Fan, MO Tang, WH … - Circulation, 2002 - Am Heart Assoc
... heart failure: preliminary results of the Medtronic Inc in ... Eur Heart J. 1996; 17:
1694?1702.[Medline ... A new method for estimating left ventricular dP/dt by ...

… atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart … -
EA Stephenson, D Casavant, J Tuzi, ME Alexander, I … - The American Journal of Cardiology, 2003 - Elsevier
... Patients with repaired congenital heart disease (CHD ... described herein (7253 AT500;
Medtronic, Minneapolis, Minnesota ... New York Heart Association class was ...

Source: Google Scholar

Medtronic Insertable Heart Monitor Gives New Insight Into Heart Rhythm Disorder
Last week Medtronic, Inc. (NYSE: MDT) announced the European introduction of Reveal® XT, the first Insertable Cardiac Monitor that offers long-term and continuous monitoring of Atrial Fibrillation (AF). All other current monitoring tools are either for a limited period or on an intermittent basis. Long-term, continuous monitoring means that a clinician no longer needs to rely only on incomplete data to evaluate how AF may be progressing or treatment effectiveness. The device recently received CE (Conformité Européenne) Mark, and the first implant of Reveal XT took place at Asklepios Klinik St. Georg in Hamburg, Germany by Prof. Karl-Heinz Kuck, M.D. The Reveal XT insertable cardiac monitor is not currently available for sale in the United States.
AF is the most common cardiac arrhythmia, experienced by 4.5 million patients in Europe1. Treatment of AF is difficult as episodes often show no symptoms and therefore go unnoticed by patients2. Yet the risks are well known - AF can lead to a two to seven times higher risk of stroke1, an increased risk of heart failure and sudden cardiac death3 due to inefficient pumping in the heart.

"Atrial fibrillation is the most frequent cardiac arrhythmia. It is often accompanied by symptoms that are very unpleasant for the patient," said Prof. Kuck, Hanseatisches Herzzentrum / Department of Cardiology, Asklepios Klinik St. Georg. "Moreover, atrial fibrillation is linked with increased mortality and an increase in the incidence of stroke, by a factor of two- to seven-fold. However, with the new Reveal XT, atrial fibrillation can now be scrutinized over a period of three years with a subcutaneous monitor. This gives us totally new possibilities for monitoring and adjusting the treatment."

The Only Way of Precisely Treating AF Is Knowing AF

The Reveal XT Insertable Cardiac Monitor monitors AF patients 24 hours a day, every day for up to three years. There are a variety of ways to treat AF, but up until now physicians had no means of gathering detailed data, over an extended period, on the progression of AF and the effect of treatment. Reveal XT gives new insight into patients' heart rhythms, which may help physicians to evaluate stroke risk and determine appropriate treatment and therapy options for their patients.

24/7 Monitoring Provides Patient Compliance

As Reveal XT is inserted just under the skin, the patient experiences no restrictions in daily activities. This is not only more comfortable for the patient, but also ensures that cardiac data recorded is not influenced by restrictions in activities. Patients continue to lead their normal life and therefore heart activity recorded shows real-life, relevant information. Once patients leave the clinic, Reveal XT does not require wires or sticky pads to monitor the patients' heart rhythms.

1 ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation
2 T. Fetsch, EHJ. 2004;1385-1394
3 A. Krahn et al. Am J Med. 1995; 98:476-484

About Medtronic

Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

http://www.medtronic.com
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.